Dear Colleagues,

Lung transplantation is a clinical reality for the treatment of benign end-stage respiratory diseases today. Candidates’ selection and correct timing, evaluation and management of potential donors, and therapy and post-transplant monitoring are certainly the most relevant aspects of this complicated path. Although great progress has been achieved in the overall approach, the results can still be improved, especially in terms of mortality and survival rates. The most relevant aspect is the incomplete understanding of the physiopathological mechanisms underlying the different phases of the donation–transplant process, from lung damage in the donor to chronic rejection in the recipient. In addition, the lack of harmony and contact between basic and clinical research has a great impact in an area where the two aspects should closely interact. This Special Issue aims to address the current and more challenging topics in the lung transplant scenario, facilitating a moment of dynamic debate between clinicians and researchers and providing the necessary tools to merge experiences.

This Special Issue aims to address the most current and challenging topics in the lung transplant scenario, facilitating a moment of dynamic debate between clinicians and physicians, providing the tools necessary to merge experiences.

We look forward to your contribution.

Dr. Alessandro Palleschi
Dr. Davide Tosi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• the history of lung transplantation
• recipients: referral and listing
• DBD donors
• DCD donors
• living donors
• bridge to transplant
• machine perfusion
• intraoperative extracorporeal support
• primary graft dysfunction
• post-transplant prophylaxis
• post-transplant surveillance
• acute rejection
• chronic rejection
• post-transplant tumors
• bronchial complications
• retransplant
• combined transplant
• animal models for the study of lung transplantation
• the artificial lung

• Advances in Lung Transplantation in Cells (7 articles)